RESTASIS .5 mg/mL (Cyclosporine EMULSION) .5 mg/mL

RESTASIS .5 mg/mL is an ophthalmic emulsion containing cyclosporine. It is designed to help increase tear production in individuals with chronic dry eye disease. This prescription treatment aims to improve eye comfort and reduce dryness.

Strength

.5 mg/mL

Pack Size

5 VIAL, SINGLE-USE in 1 CARTON (0023-9163-12) / .4 mL in 1 VIAL, SINGLE-USE

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RESTASIS .5 mg/mL is primarily used to treat chronic dry eye disease. It works by increasing the production of tears, which can help alleviate symptoms such as dryness, irritation, and discomfort. This medication is often recommended for individuals who experience persistent dry eye symptoms that do not respond to artificial tears or other over-the-counter treatments.

Side Effects

Common effects of RESTASIS .5 mg/mL may include temporary burning or stinging upon application. Some users may also experience redness or itching in the eyes. These effects are usually mild and transient, but if they persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

RESTASIS .5 mg/mL should be handled with care to avoid contamination. The single-use vials should not be reused. It is important to follow proper hygiene practices when administering the emulsion. Individuals with a history of eye infections or other eye conditions should use this medication under the guidance of a healthcare professional.

Avoid Interactions

RESTASIS .5 mg/mL may interact with other ophthalmic medications. It is advisable to inform your healthcare provider about all medications you are currently using. Additionally, avoid using contact lenses while applying this medication, as it may cause irritation or discomfort.

Frequently Asked Questions

RESTASIS .5 mg/mL is used to increase tear production in individuals with chronic dry eye disease, helping to alleviate symptoms of dryness and discomfort.

RESTASIS .5 mg/mL is applied as an eye emulsion. Follow the instructions provided by your healthcare professional for proper administration.

Common side effects may include temporary burning, stinging, redness, or itching in the eyes. These effects are usually mild and transient.

It is generally recommended to avoid using contact lenses while applying RESTASIS .5 mg/mL to prevent irritation or discomfort.

RESTASIS .5 mg/mL should be stored at room temperature, away from direct sunlight and moisture. Keep the vials in their original packaging until use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.